期刊文献+

阳离子通道阻断剂-钌红促进破骨细胞分化的影响 被引量:1

Cation channel blocker-.ruthenium red promoted osteoclastogenesis
原文传递
导出
摘要 目的探讨阳离子通道阻断剂钌红对破骨细胞分化的影响及其机制。方法钌红处理Raw246.7后,50μg/L核因子.KB受体活化因子配体(RANKL)诱导6d,抗酒石酸酸性磷酸酶(TRAP)染色观察TRAP+(核93)细胞的形成;TRAP试剂盒检测细胞中TRAP酶的活性;实时定量逆转录聚合酶链反应(FIT—qPCR)检测破骨细胞特异性标志基因TRAP、组织蛋白酶K(CK)和金属基质蛋白酶-9(MMPO)mRNA表达量;RT.qPCR、Westernblot分别检测核因子-κB受体活化因子(RANK)在mRNA和蛋白水平上的表达。结果钌红促进RANKL诱导Raw246.7细胞形成TRAP阳性多核细胞,对照组TRAP吸光度(A)值为0.33±0.04,而钌红组TRAPA值为0.43±0.03;同时也上调了破骨细胞标志性基因TRAP、CK和MMPO的mRNA表达以及RANK在mRNA和蛋白水平的表达。各指标在两组中的差异有统计学意义(P〈0105)。结论钌红促进Raw246.7向破骨细胞分化,这一过程与钌红上调RANK表达有关,即与RANK—RANKL轴相关。 Objective To investigate the effects of ruthenium red on the differentiation of osteo- clasts and relative mechanism. Methods Receptor activator of nuclear factor-KB ligand (RANKL) was used to stimulate osteoclast differentiation. Osteoclast differentiation was assessed by tartrate-resistant acid phosphatase (TRAP) staining and the TRAP-positive cells were counted after exposure to 50 μg/L RANKL for 6 days. Tartrate-resistant acid phosphatase kit was used to evaluate TRAP activity. The expression of osteoclast specific genes [ TRAP, Capthesin K ( CK), matrix metalloproteinase (MMP) -9 ] mRNA expres- sion was detected by using real-time quantitative reverse transcription-polymerase chain reaction (RT-qPCR). The receptor activator of nuclear factor Kb(RANK) mRNA and protein expression was also detected. Results Ruthenium red promoted RANKL-stimulated osteoclast differentiation in Raw246.7 cell culture, as manifested by the increase of TRAP positive muhinucleated cells and TRAP activity. In control group the TRAP A was 0. 33 ± 0. 04, and that in ruthenium red group was 0. 43± 0. 03. Ruthenium also up-regulated TRAP, CK, MMP-9 and RANK mRNA expression, and increased RANK protein expression. The difference between two groups was significant ( P 〈 0. 05 ). Conclusion Ruthenium red promoted oste- oclast differentiation, which might by related to RANK-RANKL axis.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2013年第4期784-786,共3页 Chinese Journal of Experimental Surgery
关键词 钌红 破骨细胞 分化 Ruthenium red Osteoclastst Differentiation
  • 相关文献

参考文献15

  • 1耿德春,徐耀增,朱雪松,王骏骅,王根林,杨惠林.大麻素受体CB2选择性抑制剂对RAW264.7细胞分化为破骨细胞的作用[J].中华实验外科杂志,2011,28(5):784-786. 被引量:9
  • 2Kawatani M, Okumura H, Honda K, et al. The identilication oi an os- teoclastogenesis inhibitor through the inhibition of glyoxalase I. Proc Natl Acad Sci U S A ,2008,105 : 11691-11696.
  • 3Yee AJ,Raje NS. Denosumab,a RANK ligand inhibitor,for the man- agement of bone loss in cancer patients. Clin Interv Aging,2012,7: 331-338.
  • 4Kajiya H, Okamoto F, Nemoto T, et al. RANKL-induced TRPV2 ex- pression regulates osteoclastogenesis via calcium oscillations. Cell Cal- cium,2010,48:260-269.
  • 5Ernest N J, Logsdon N J, McFerrin MB, et al. Biophysical properties of human medullobIastoma cells. J Membr Bio1,2010 ,237 :59-69.
  • 6Kim D, Cavanaugh EJ, Kim I, et al. Heteromeric TASK-I/TASK-3 is the major oxygen-sensitive background K + channel in rat carotid body glomus cells. J Physiol,2009,587:2963-2975.
  • 7Kato K, Morita I. Acidosis environment promotes osteoclast formation by acting on the last phase of preosteoclast differentiation:a study to elucidate the action points of acidosis and search for putative target molecules. Eur J Pharmaco1,2011,663 :27-39.
  • 8梁晚益,杨宗城,黄跃生.钌红对严重烧伤早期心肌能量代谢的影响[J].中华实验外科杂志,2001,18(2):163-164. 被引量:4
  • 9Hu W, Yang X, Zhe C, et al. Puerarin inhibits iNl_lS, COX-2 and CRP expression via suppression of NF-kappaB activation in LPS-induced RAW264. 7 macrophage cells. Pharmacol Rep ,2011,63:781-789.
  • 10Humphrey MB, Daws MR, Spusta SC, et al. TREM2, a DAP12-associ- ated receptor, regulates osteoclast differentiation and function. J Bone Miner Res,2006,21:237-245.

二级参考文献33

  • 1李月白,胡新永,王卫东,王义生.一氧化氮在糖皮质激素性骨质疏松发病中的作用和辛伐他汀对骨代谢的影响[J].中华实验外科杂志,2006,23(2):144-146. 被引量:10
  • 2李宏斌,朱振安,毛远青,严孟宁,汤亭亭,侯筱魁,戴尅戎.阿仑膦酸钠预防磨损颗粒诱导假体周围骨溶解的作用机制[J].中华实验外科杂志,2006,23(2):154-156. 被引量:19
  • 3刘兴炎,吕明波,葛宝丰,白孟海,陈克明.淫羊藿苷对小鼠破骨细胞β-肌动蛋白、抗酒石酸酸性磷酸酶、核因子-κB受体活化因子mRNA表达的影响[J].中华实验外科杂志,2007,24(8):996-998. 被引量:20
  • 4Teitelbaum SL.Osteoclast:what do they do and how do they do it?Am J Pathol,2007,170:427-435.
  • 5Idris AI,Sophocleous A,Landao-Bassonga E,et al.Regulation of bone mass,osteoclast function and ovariectomy-induced bone loss by the type 2 cannabinoid receptor.Endocrinology,2008,149:5619-5626.
  • 6Geng D,Xu Y,Yang H,et al.Protection against titanium particle induced osteolysis by cannabinoid receptor 2 selective antagonist.Biomaterials,2010,31:1996-2000.
  • 7Hofbauer LC.Schoppet M.Clinical implications of the osteoprotegerin RANKL/RANK system for bone and vascular diseases.JAMA,2004,292:490-495.
  • 8Ducy P,Schinke T,Karsenty G.The ostoeblast:a sophisticated fibroblast under central surveillance.Science,2000,289; 1501-1504.
  • 9Vestergaard P,Rejnmark L,Mosekilde L.Relative fracture risk in patients with diabetes mellitus,and the impact of insulin and oral antidiabetic medication on relative fracture risk.Diabetologia,2005,48(7):1292-1299.
  • 10Kanazawa I,Yamaguchi T,Yano S,et al.Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression.Biochem Biophys Res Commun,2008,375(3):414-419.

共引文献17

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部